{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:22:10Z","timestamp":1786429330629,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Scientific Research\u00a0Program for\u00a0Young\u00a0and Middle-aged Health Professionals of\u00a0Fujian Province, China","award":["2022ZQNZD002"],"award-info":[{"award-number":["2022ZQNZD002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00277-025-06487-8","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T02:37:58Z","timestamp":1752719878000},"page":"3791-3801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rethinking bone marrow biopsy: is PET\/CT enough for staging low-grade follicular lymphomas?"],"prefix":"10.1007","volume":"104","author":[{"given":"Yan-Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Huan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Qin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Qing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"5","key":"6487_CR1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/s0360-3016(01)01747-3","volume":"51","author":"RB Wilder","year":"2001","unstructured":"Wilder RB, Jones D, Tucker SL, Fuller LM, Ha CS, McLaughlin P, Hess MA, Cabanillas F, Cox JD (2001) Long-term results with radiotherapy for stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 51(5):1219\u20131227. https:\/\/doi.org\/10.1016\/s0360-3016(01)01747-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6487_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/leu.2014.251","volume":"29","author":"HR Junl\u00e9n","year":"2015","unstructured":"Junl\u00e9n HR, Peterson S, Kimby E, Lockmer S, Lind\u00e9n O, Nilsson-Ehle H, Erlanson M, Hagberg H, R\u00e5dlund A, Hagberg O, Wahlin BE (2015) Follicular lymphoma in sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish lymphoma registry study. Leukemia 29(3):668\u2013676. https:\/\/doi.org\/10.1038\/leu.2014.251","journal-title":"Leukemia"},{"issue":"7","key":"6487_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2967\/jnumed.122.265199","volume":"64","author":"AK Buck","year":"2023","unstructured":"Buck AK, Serfling SE, Kraus S, Samnick S, Dreher N, Higuchi T, Rasche L, Einsele H, Werner RA (2023) Theranostics in hematooncology. J Nucl Med 64(7):1009\u20131016. https:\/\/doi.org\/10.2967\/jnumed.122.265199","journal-title":"J Nucl Med"},{"issue":"suppl 5","key":"6487_CR4","doi-asserted-by":"publisher","first-page":"v83","DOI":"10.1093\/annonc\/mdw400","volume":"27","author":"M Dreyling","year":"2016","unstructured":"Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M (2016) Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v83\u2013v90. https:\/\/doi.org\/10.1093\/annonc\/mdw400","journal-title":"Ann Oncol"},{"issue":"2","key":"6487_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s11864-014-0286-4","volume":"15","author":"J Yahalom","year":"2014","unstructured":"Yahalom J (2014) Radiotherapy of follicular lymphoma: updated role and new rules. Curr Treat Options Oncol 15(2):262\u2013268. https:\/\/doi.org\/10.1007\/s11864-014-0286-4","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"6487_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.6004\/jnccn.2023.0057","volume":"21","author":"AD Zelenetz","year":"2023","unstructured":"Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis B, Bartlett NL, Budde LE, Caimi PF, Chang JE, Christian B, DeVos S, Dholaria B, Fayad LE, Habermann TM, Hamid MS, Hernandez-Ilizaliturri F, Hu B, Kaminski MS, Karimi Y, Kelsey CR, King R, Krivacic S, LaCasce AS, Lim M, Messmer M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2023) NCCN Guidelines\u00ae insights: B-Cell lymphomas, version 6.2023. J Natl Compr Canc Netw 21(11):1118\u20131131. https:\/\/doi.org\/10.6004\/jnccn.2023.0057","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"6487_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","volume":"32","author":"M Dreyling","year":"2021","unstructured":"Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, Herfarth K, Seymour JF, Jerkeman M (2021) Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):298\u2013308. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.008","journal-title":"Ann Oncol"},{"issue":"8","key":"6487_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.5858\/2004-128-863-aceofl","volume":"128","author":"ED Hsi","year":"2004","unstructured":"Hsi ED, Mirza I, Lozanski G, Hill J, Pohlman B, Karafa MT, Coupland R (2004) A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Arch Pathol Lab Med 128(8):863\u2013868. https:\/\/doi.org\/10.5858\/2004-128-863-aceofl","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"6487_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/annonc\/mdq574","volume":"22","author":"J Shustik","year":"2011","unstructured":"Shustik J, Quinn M, Connors JM, Gascoyne RD, Skinnider B, Sehn LH (2011) Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Ann Oncol 22(5):1164\u20131169. https:\/\/doi.org\/10.1093\/annonc\/mdq574","journal-title":"Ann Oncol"},{"issue":"11","key":"6487_CR10","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.humpath.2013.06.013","volume":"44","author":"AM Maeshima","year":"2013","unstructured":"Maeshima AM, Taniguchi H, Nomoto J, Miyamoto K, Fukuhara S, Munakata W, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Tsuda H (2013) Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy. Hum Pathol 44(11):2529\u20132535. https:\/\/doi.org\/10.1016\/j.humpath.2013.06.013","journal-title":"Hum Pathol"},{"issue":"3","key":"6487_CR11","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","volume":"64","author":"BA Guadagnolo","year":"2006","unstructured":"Guadagnolo BA, Li S, Neuberg D, Ng A, Hua L, Silver B, Stevenson MA, Mauch P (2006) Long-term outcome and mortality trends in early-stage, grade 1\u20132 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 64(3):928\u2013934. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.08.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"29","key":"6487_CR12","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1200\/jco.2018.77.9892","volume":"36","author":"M MacManus","year":"2018","unstructured":"MacManus M, Fisher R, Roos D, O\u2019Brien P, Macann A, Davis S, Tsang R, Christie D, McClure B, Joseph D, Jayamohan J, Seymour JF (2018) Randomized trial of systemic therapy after Involved-Field radiotherapy in patients with Early-Stage follicular lymphoma: TROG 99.03. J Clin Oncol 36(29):2918\u20132925. https:\/\/doi.org\/10.1200\/jco.2018.77.9892","journal-title":"J Clin Oncol"},{"issue":"3","key":"6487_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/0003-4819-82-3-365","volume":"82","author":"RD Brunning","year":"1975","unstructured":"Brunning RD, Bloomfield CD, McKenna RW, Peterson LA (1975) Bilateral Trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 82(3):365\u2013366. https:\/\/doi.org\/10.7326\/0003-4819-82-3-365","journal-title":"Ann Intern Med"},{"issue":"9","key":"6487_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.1971.03190090061014","volume":"217","author":"T Han","year":"1971","unstructured":"Han T, Stutzman L, Rogue AL (1971) Bone marrow biopsy in hodgkin\u2019s disease and other neoplastic diseases. JAMA 217(9):1239\u20131241","journal-title":"JAMA"},{"issue":"27","key":"6487_CR15","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espanol, de Medula O, German High-Grade Lymphoma Study G, German Hodgkin\u2019s Study, Japanese G, Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study, Southwest Oncology G, G, United Kingdom National Cancer Research I (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"8","key":"6487_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2967\/jnumed.116.184218","volume":"58","author":"C Zwarthoed","year":"2017","unstructured":"Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, Viviani S, Rigacci L, Trentin L, Rusconi C, Luminari S, Cantonetti M, Bolis S, Borra A, Darcourt J, Salvi F, Subocz E, Tajer J, Kulikowski W, Malkowski B, Zaucha JM, Gallamini A (2017) Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in hodgkin lymphoma: results from an international collaborative study. J Nucl Med 58(8):1249\u20131254. https:\/\/doi.org\/10.2967\/jnumed.116.184218","journal-title":"J Nucl Med"},{"issue":"36","key":"6487_CR17","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1200\/jco.2012.42.4036","volume":"30","author":"TC El-Galaly","year":"2012","unstructured":"El-Galaly TC, d\u2019Amore F, Mylam KJ, de Nully Brown P, B\u00f8gsted M, Bukh A, Specht L, Loft A, Iyer V, Hjorthaug K, Nielsen AL, Christiansen I, Madsen C, Johnsen HE, Hutchings M (2012) Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-naive patients with hodgkin lymphoma. J Clin Oncol 30(36):4508\u20134514. https:\/\/doi.org\/10.1200\/jco.2012.42.4036","journal-title":"J Clin Oncol"},{"issue":"8","key":"6487_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","volume":"54","author":"L Berthet","year":"2013","unstructured":"Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F (2013) In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med 54(8):1244\u20131250. https:\/\/doi.org\/10.2967\/jnumed.112.114710","journal-title":"J Nucl Med"},{"issue":"1","key":"6487_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","volume":"122","author":"AB Khan","year":"2013","unstructured":"Khan AB, Barrington SF, Mikhaeel NG, Hunt AA, Cameron L, Morris T, Carr R (2013) PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood 122(1):61\u201367. https:\/\/doi.org\/10.1182\/blood-2012-12-473389","journal-title":"Blood"},{"issue":"22","key":"6487_CR20","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1002\/cncr.34473","volume":"128","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wang JJ, Zhao RZ, Huang C, Shi GQ, Zheng H, Tang TL, Liao SQ, Chen JH, Shen JZ, Liu TB, Xu BH, Zhang YJ (2022) The value of routine bone marrow examination in patients with extranodal NK\/T-cell lymphoma staged with PET\/CT. Cancer 128(22):3943\u20133950. https:\/\/doi.org\/10.1002\/cncr.34473","journal-title":"Cancer"},{"issue":"3","key":"6487_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjh.14071","volume":"174","author":"CS Ujjani","year":"2016","unstructured":"Ujjani CS, Hill EM, Wang H, Nassif S, Esposito G, Ozdemirli M, Cordova C, Cheson BD (2016) (18) F-FDG PET-CT and Trephine biopsy assessment of bone marrow involvement in lymphoma. Br J Haematol 174(3):410\u2013416. https:\/\/doi.org\/10.1111\/bjh.14071","journal-title":"Br J Haematol"},{"issue":"12","key":"6487_CR22","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1177\/0284185117701305","volume":"58","author":"AR Teagle","year":"2017","unstructured":"Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T (2017) Use of FDG PET\/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with Iliac crest bone marrow biopsy. Acta Radiol 58(12):1476\u20131484. https:\/\/doi.org\/10.1177\/0284185117701305","journal-title":"Acta Radiol"},{"issue":"6","key":"6487_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.blre.2015.06.003","volume":"29","author":"HJ Adams","year":"2015","unstructured":"Adams HJ, Nievelstein RA, Kwee TC (2015) Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Rev 29(6):417\u2013425. https:\/\/doi.org\/10.1016\/j.blre.2015.06.003","journal-title":"Blood Rev"},{"issue":"5","key":"6487_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdt533","volume":"25","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS, Nievelstein RA (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25(5):921\u2013927. https:\/\/doi.org\/10.1093\/annonc\/mdt533","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"6487_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2007.2001","volume":"5","author":"DA Podoloff","year":"2007","unstructured":"Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr., Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD (2007) NCCN task force report: positron emission tomography (PET)\/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 5(Suppl 1):S1\u201322 quiz S23-22","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"6487_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1634\/theoncologist.2019-0952","volume":"25","author":"F St-Pierre","year":"2020","unstructured":"St-Pierre F, Broski SM, LaPlant BR, Maurer MJ, Ristow K, Thanarajasingam G, Macon WR, Habermann TM, Witzig TE (2020) Fluorodeoxyglucose-Positron emission tomography predicts bone marrow involvement in the staging of follicular lymphoma. Oncologist 25(8):689\u2013695. https:\/\/doi.org\/10.1634\/theoncologist.2019-0952","journal-title":"Oncologist"},{"issue":"7","key":"6487_CR27","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ajh.25493","volume":"94","author":"F St-Pierre","year":"2019","unstructured":"St-Pierre F, Broski SM, LaPlant BR, Ristow K, Maurer MJ, Macon WR, Habermann TM, Ansell SM, Thompson CA, Micallef INM, Nowakowski GS, Witzig TE (2019) Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma. Am J Hematol 94(7):786\u2013793. https:\/\/doi.org\/10.1002\/ajh.25493","journal-title":"Am J Hematol"},{"issue":"1","key":"6487_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/rct.0000000000000485","volume":"41","author":"HJ Adams","year":"2017","unstructured":"Adams HJ, Nievelstein RA, Kwee TC (2017) Systematic review on the additional value of 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography in staging follicular lymphoma. J Comput Assist Tomogr 41(1):98\u2013103. https:\/\/doi.org\/10.1097\/rct.0000000000000485","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"6487_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/mnm.0000000000000059","volume":"35","author":"I El-Najjar","year":"2014","unstructured":"El-Najjar I, Montoto S, McDowell A, Matthews J, Gribben J, Szyszko TA (2014) The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma. Nucl Med Commun 35(3):311\u2013315. https:\/\/doi.org\/10.1097\/mnm.0000000000000059","journal-title":"Nucl Med Commun"},{"issue":"1","key":"6487_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","volume":"71","author":"A Wirth","year":"2008","unstructured":"Wirth A, Foo M, Seymour JF, Macmanus MP, Hicks RJ (2008) Impact of [18f] Fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma. Int J Radiat Oncol Biol Phys 71(1):213\u2013219. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.09.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"6487_CR31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","volume":"24","author":"S Luminari","year":"2013","unstructured":"Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F, Spina M, Ferreri AJ, Zinzani PL, Gallamini A, Mastronardi S, Boccomini C, Gaidano G, D\u2019Arco AM, Di Raimondo F, Carella AM, Santoro A, Musto P, Federico M (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana linfomi. Ann Oncol 24(8):2108\u20132112. https:\/\/doi.org\/10.1093\/annonc\/mdt137","journal-title":"Ann Oncol"},{"issue":"12","key":"6487_CR32","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Le Dortz","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y, Cuggia M, Le Jeune F, Bahri H, Barge ML, Lamy T, Garin E (2010) Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 37(12):2307\u20132314. https:\/\/doi.org\/10.1007\/s00259-010-1539-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"6487_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/10428194.2013.802784","volume":"55","author":"M Meignan","year":"2014","unstructured":"Meignan M, Barrington S, Itti E, Gallamini A, Haioun C, Polliack A (2014) Report on the 4th international workshop on positron emission tomography in lymphoma held in menton, france, 3\u20135 October 2012. Leuk Lymphoma 55(1):31\u201337. https:\/\/doi.org\/10.3109\/10428194.2013.802784","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"6487_CR34","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","volume":"101","author":"CP Hans","year":"2003","unstructured":"Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P, Greiner TC, Chan WC, Bociek RG, Bierman PJ, Armitage JO (2003) A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 101(6):2363\u20132367. https:\/\/doi.org\/10.1182\/blood-2002-07-2298","journal-title":"Blood"},{"issue":"7","key":"6487_CR35","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1182\/blood.V93.7.2202","volume":"93","author":"J Rodriguez","year":"1999","unstructured":"Rodriguez J, McLaughlin P, Hagemeister FB, Fayad L, Rodriguez MA, Santiago M, Hess M, Romaguera J, Cabanillas F (1999) Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood 93(7):2202\u20132207","journal-title":"Blood"},{"issue":"1","key":"6487_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.bjc.6601006","volume":"89","author":"I Chau","year":"2003","unstructured":"Chau I, Jones R, Cunningham D, Wotherspoon A, Maisey N, Norman AR, Jain P, Bishop L, Horwich A, Catovsky D (2003) Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? Br J Cancer 89(1):36\u201342. https:\/\/doi.org\/10.1038\/sj.bjc.6601006","journal-title":"Br J Cancer"},{"issue":"12","key":"6487_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/01.pas.0000182405.65041.8b","volume":"29","author":"DA Arber","year":"2005","unstructured":"Arber DA, George TI (2005) Bone marrow biopsy involvement by non-Hodgkin\u2019s lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 29(12):1549\u20131557. https:\/\/doi.org\/10.1097\/01.pas.0000182405.65041.8b","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"6487_CR38","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"7","key":"6487_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ajh.23730","volume":"89","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM (2014) Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Am J Hematol 89(7):726\u2013731. https:\/\/doi.org\/10.1002\/ajh.23730","journal-title":"Am J Hematol"},{"issue":"27","key":"6487_CR40","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/jco.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, M\u00fceller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O\u2019Doherty MJ, Hustinx R, Biggi A, Cheson BD (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048\u20133058. https:\/\/doi.org\/10.1200\/jco.2013.53.5229","journal-title":"J Clin Oncol"},{"issue":"12","key":"6487_CR41","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/ajh.26737","volume":"97","author":"E Jacobsen","year":"2022","unstructured":"Jacobsen E (2022) Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol 97(12):1638\u20131651. https:\/\/doi.org\/10.1002\/ajh.26737","journal-title":"Am J Hematol"},{"key":"6487_CR42","doi-asserted-by":"publisher","first-page":"863021","DOI":"10.3389\/fonc.2022.863021","volume":"12","author":"F Gao","year":"2022","unstructured":"Gao F, Zhang T, Liu X, Qu Z, Liu X, Li L, Qiu L, Qian Z, Zhou S, Gong W, Meng B, Ren X, Wang X, Zhang H (2022) Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China. Front Oncol 12:863021. https:\/\/doi.org\/10.3389\/fonc.2022.863021","journal-title":"Front Oncol"},{"issue":"9","key":"6487_CR43","doi-asserted-by":"publisher","first-page":"e2910","DOI":"10.1097\/md.0000000000002910","volume":"95","author":"C Perry","year":"2016","unstructured":"Perry C, Lerman H, Joffe E, Sarid N, Amit O, Avivi I, Kesler M, Ben-Ezra J, Even-Sapir E, Herishanu Y (2016) The value of PET\/CT in detecting bone marrow involvement in patients with follicular lymphoma. Medicine (Baltimore) 95(9):e2910. https:\/\/doi.org\/10.1097\/md.0000000000002910","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"6487_CR44","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1182\/bloodadvances.2020001579","volume":"4","author":"R Nakajima","year":"2020","unstructured":"Nakajima R, Moskowitz AJ, Michaud L, Mauguen A, Batlevi CL, Dogan A, Schoder H (2020) Baseline FDG-PET\/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information. Blood Adv 4(8):1812\u20131823. https:\/\/doi.org\/10.1182\/bloodadvances.2020001579","journal-title":"Blood Adv"},{"issue":"3","key":"6487_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.remnie.2022.03.002","volume":"41","author":"A D\u00edaz-Silv\u00e1n","year":"2022","unstructured":"D\u00edaz-Silv\u00e1n A, Ot\u00f3n-S\u00e1nchez LF, Caresia-Ar\u00f3ztegui AP, Del Puig C\u00f3zar-Santiago M, Orcajo-Rinc\u00f3n J, de Arcocha-Torres M, Delgado-Bolton RC, Cabello-Garc\u00eda D (2022) Clinical application of [(18)F]FDG PET\/CT in follicular lymphoma. Rev Esp Med Nucl Imagen Mol (Engl Ed) 41(3):202\u2013212. https:\/\/doi.org\/10.1016\/j.remnie.2022.03.002","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"issue":"14","key":"6487_CR46","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.7150\/jca.87523","volume":"14","author":"Y Jing","year":"2023","unstructured":"Jing Y, Chen Y, Yu Y, Zhao H, Yang H, Sun B, Wang X (2023) FDG-PET\/CT provides clues on bone marrow involvement in follicular lymphoma and carries important prognostic information. J Cancer 14(14):2726\u20132738. https:\/\/doi.org\/10.7150\/jca.87523","journal-title":"J Cancer"},{"issue":"6","key":"6487_CR47","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1002\/cam4.5424","volume":"12","author":"I R\u00f3denas-Qui\u00f1onero","year":"2023","unstructured":"R\u00f3denas-Qui\u00f1onero I, Chen-Liang T, Mart\u00edn-Santos T, Salar A, Fern\u00e1ndez-Gonz\u00e1lez M, Celades C, Navarro JT, Mart\u00ednez-Garcia AB, Andreu R, Balaguer A, Martin Garc\u00eda-Sancho A, Baile M, L\u00f3pez-Jim\u00e9nez J, Marquet-Palomanes J, Teruel AI, Terol MJ, Benet C, Frutos L, Navarro JL, U\u00f1a J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguil\u00f3n-Gallego L, S\u00e1nchez-Blanco JJ, P\u00e9rez-Ceballos E, Jerez A, Ortu\u00f1o FJ (2023) Accuracy and prognostic impact of FDG PET\/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Cancer Med 12(6):6536\u20136546. https:\/\/doi.org\/10.1002\/cam4.5424","journal-title":"Cancer Med"},{"issue":"5","key":"6487_CR48","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Ha\u00efoun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258\u20131265. https:\/\/doi.org\/10.1182\/blood-2003-12-4434","journal-title":"Blood"},{"issue":"27","key":"6487_CR49","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/jco.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-C\u00e9ligny P (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562. https:\/\/doi.org\/10.1200\/jco.2008.21.3991","journal-title":"J Clin Oncol"},{"issue":"2","key":"6487_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2141.2011.08942.x","volume":"156","author":"BE Wahlin","year":"2012","unstructured":"Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundstr\u00f6m C, Christensson B, Sander B (2012) Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol 156(2):225\u2013233. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08942.x","journal-title":"Br J Haematol"},{"issue":"3","key":"6487_CR51","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2004.05046.x","volume":"126","author":"D Canioni","year":"2004","unstructured":"Canioni D, Brice P, Lepage E, Chababi M, Meignin V, Salles B, Xerri L, P\u00e9aud PY, Rousselot P, Peuchmaur M, Solal-C\u00e9ligny P, Brousse N (2004) Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the groupe d\u2019etude des lymphomes folliculaires. Br J Haematol 126(3):364\u2013371. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05046.x","journal-title":"Br J Haematol"},{"issue":"7","key":"6487_CR52","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/jco.1990.8.7.1163","volume":"8","author":"MG Conlan","year":"1990","unstructured":"Conlan MG, Bast M, Armitage JO, Weisenburger DD (1990) Bone marrow involvement by non-Hodgkin\u2019s lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska lymphoma study group. J Clin Oncol 8(7):1163\u20131172. https:\/\/doi.org\/10.1200\/jco.1990.8.7.1163","journal-title":"J Clin Oncol"},{"issue":"5","key":"6487_CR53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/annonc\/mdl014","volume":"17","author":"S Wohrer","year":"2006","unstructured":"Wohrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K, Raderer M, Hoffmann M (2006) 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 17(5):780\u2013784. https:\/\/doi.org\/10.1093\/annonc\/mdl014","journal-title":"Ann Oncol"},{"issue":"5","key":"6487_CR54","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood-2004-01-0379","volume":"105","author":"TP Vassilakopoulos","year":"2005","unstructured":"Vassilakopoulos TP, Angelopoulou MK, Constantinou N, Karmiris T, Repoussis P, Roussou P, Siakantaris MP, Korkolopoulou P, Kyrtsonis MC, Kokoris SI, Dimopoulou MN, Variamis E, Viniou NA, Konstantopoulos K, Dimitriadou EM, Androulaki A, Patsouris E, Doussis-Anagnostopoulou IA, Panayiotidis P, Boussiotis VA, Kittas C, Pangalis GA (2005) Development and validation of a clinical prediction rule for bone marrow involvement in patients with hodgkin lymphoma. Blood 105(5):1875\u20131880. https:\/\/doi.org\/10.1182\/blood-2004-01-0379","journal-title":"Blood"},{"issue":"1","key":"6487_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3816\/clm.2004.n.010","volume":"5","author":"A Levis","year":"2004","unstructured":"Levis A, Pietrasanta D, Godio L, Vitolo U, Ciravegna G, Di Vito F, Gavarotti P, Guglielmelli T, Orsucci L, Raviolo E, Rota Scalabrini D, Salvi F, Tonso A, Aglietta M, Boccadoro M, Gallamini A, Saglio G, Scassa E, Gallo E (2004) A large-scale study of bone marrow involvement in patients with hodgkin\u2019s lymphoma. Clin Lymphoma 5(1):50\u201355. https:\/\/doi.org\/10.3816\/clm.2004.n.010","journal-title":"Clin Lymphoma"},{"issue":"1","key":"6487_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1078-0432.Ccr-22-1654","volume":"29","author":"I Fern\u00e1ndez-Miranda","year":"2023","unstructured":"Fern\u00e1ndez-Miranda I, Pedrosa L, Llanos M, Franco FF, G\u00f3mez S, Mart\u00edn-Acosta P, Garc\u00eda-Arroyo FR, Gum\u00e1 J, Horcajo B, Ballesteros AK, G\u00e1lvez L, Mart\u00ednez N, Mar\u00edn M, Sequero S, Navarro M, Yanguas-Cas\u00e1s N, Calvo V, Rueda-Dom\u00ednguez A, Provencio M, S\u00e1nchez-Beato M (2023) Monitoring of Circulating tumor DNA predicts response to treatment and early progression in follicular lymphoma: results of a prospective pilot study. Clin Cancer Res 29(1):209\u2013220. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-1654","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06487-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06487-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06487-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:58:24Z","timestamp":1757249904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06487-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6487"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06487-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from Fujian Medical University Union Hospital Ethics Committee (approval number: 2022WSJK019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}